CMS Directs Beneficiaries to Reach Out to Their Suppliers for Repair and Replacements of Philips Respironics Recalled Equipment

Published in Government Relations on August 26, 2021

Yesterday, CMS sent out the alert below regarding the recalled Phillips Respironics products, directing Medicare beneficiaries to reach out the suppliers they purchased the equipment from if they need it replaced or repaired. While the statement released by CMS is accurate in that most of the patients impacted by the recall should expect to have their existing device repaired or replaced, it fails to mention that the process and timeline associated with repairing or replacing those devices could take several months. We believe that should be clarified by CMS, as the current wording of the message they released will no doubt create unrealistic expectations for Medicare beneficiaries.

To that end, VGM is preparing a letter to send to CMS regarding this announcement, requesting that they issue a revised statement with additional clarification. We will keep you updated as we hear more.

PRI Medicare

In the meantime, VGM encourages providers to create clear expectations with your patients about what to expect. Below is a template that you can use as a basis of your communications with your patient base:

Philips Respironics, the manufacturer of your recalled device, has agreed to repair or replace all recalled and registered devices. Please make sure you have registered your device with them. You can complete that registration process here: https://www.philipssrcupdate.expertinquiry.com/?ulang=en or call them at 877-907-7508. Any Devices that are rentals are still owned by us, your supplier, and will be replaced by us as soon as we receive replacement devices from Philips, but the process could take several months.

There is currently a major disruption in the supply chain for these products, including both raw materials and device components. Philips is also awaiting approval from the FDA to begin repairing devices or offering replacements. Because of those factors, there are not currently enough alternate devices available to repair/replace your device. We will notify you as soon as we have the ability to offer you a replacement device.


TAGS

  1. cms
  2. medicare
  3. vgm government

From Our Experts

H.R. 5555 Gets Amended and Passes Energy and Commerce Committee thumbnail H.R. 5555 Gets Amended and Passes Energy and Commerce Committee On Wednesday, Dec. 6, The House Energy and Commerce Committee approved an amended version of H.R. 5555. The amended version of this bill extends the 75/25 blended rate in non-rural, non-CBAs through 2024 but does not include the 90/10 blended rate adjustment for suppliers in former CBAs. A Note from the SVP, Mike A Note from the SVP, Mike "Ike" Isaacson: November 2023 I hope this newsletter finds you healthy, happy, and focused on finishing out a great year! As many of you may have read, I have begun to focus more on our advocacy efforts and ensuring that VGM is here to support you in the legislative and regulatory aspects of your business. I know firsthand that some of you are dialed into the advocacy world, while others may not view these activities as an important part of your business. In our current government climate, I implore you to re-evaluate your a H.R. 5555 Gets Approved By Health Subcommittee thumbnail H.R. 5555 Gets Approved By Health Subcommittee On Wednesday, Nov. 15, the Health Subcommittee convened the health markup. The DMEPOS Relief Act of 2023 (H.R. 5555) was included in the discussion and approved. H.R. 5555 will now move on to the Energy and Commerce committee for consideration in the next few weeks. Important HME Legislation Being Discussed By Health Subcommittee on Wednesday thumbnail Important HME Legislation Being Discussed By Health Subcommittee on Wednesday On Wednesday, Nov. 15, the Health Subcommittee of the House Energy and Commerce Committee is set to meet and discuss important legislation. Included in this session will be H.R. 5555, DMEPOS Relief Act of 2023. This bill, led by Rep. Miller-Meeks (IA) and Rep. Tonko (NY) provides much-needed reimbursement relief. Read the full public memo here. Ronda Vlog: CGM News - Update On the 90 Days Billable on January 1, 2024 thumbnail Ronda Vlog: CGM News - Update On the 90 Days Billable on January 1, 2024 Be sure to listen to this important video update from Ronda Buhrmester on the upcoming change on how to bill a 90-day supply for CGMs. VGM's Ike Isaacson Gets 'Revved Up' thumbnail VGM's Ike Isaacson Gets 'Revved Up' WATERLOO, Iowa – A singular focus and a singular voice: That's what it takes to get the HME industry's message across to both lawmakers and regulators, says Mike “Ike” Isaacson, who was recently named senior vice president of government relations at VGM & Associates. A Summary of the Final Rule on the Lymphedema Treatment Act Recently Released by CMS thumbnail A Summary of the Final Rule on the Lymphedema Treatment Act Recently Released by CMS Craig Douglas, VP of Payer Relations, VGM and Associates, has reviewed the document and summarized the important information. Champions of Change Pushing for 55 in 55 Make Moves in Illinois thumbnail Champions of Change Pushing for 55 in 55 Make Moves in Illinois Champions of Change are making a strong start in the push for 55 in 55 (The goal of 55 in 55 is to schedule 55 visits with legislators and/or their staff in 55 days). Yesterday, a room of nearly 20 people gathered at VGM member, Prism Health Care Services in Schaumburg, IL to discuss S. 1294, current DME rates impacted by supply chain, delivery costs, employee costs, inflation, and so much more.